https://doi.org/10.4081/hmr.v1i6.661

Il trapianto di cellule staminali emopoietiche nei pazienti affetti da thalassemia major

Vol. 1 No. 6: XXXIV Congresso Nazionale Società Italiana Ematologia Oncologia Pediatrica
Published: June 22, 2009
Abstract Views: 289
PDF: 958
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

F Locatelli
support@pagepress.org
F Moretta
A Tolva
F Introzzi
P Merli
Il trapianto di cellule staminali emopoietiche (TCSE) rappresenta ancora oggi l’unica terapia potenzialmente curativa per i pazienti affetti da talassemia major.1 Dalla sua prima applicazione, realizzatasi con successo nel dicembre del 1981 a Seattle su un paziente pediatrico italiano,2 centinaia di procedure trapiantologiche sono state realizzate, impiegando come donatore principalmente un familiare HLA compatibile.1 3Attraverso il TCSE, una larga maggioranza di pazienti affetti da talassemia major hanno ottenuto l’indipendenza trasfusionale e la possibilità di ridurre il sovraccarico di ferro accumulatisi con le trasfusioni eritrocitarie, attraverso l’impiego regolare di procedure flebotomiche, usualmente intraprese a partire dai 3 mesi post-trapianto in presenza di valori di emoglobina superiori ai 10 gr/dL.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Locatelli, F., Moretta, F., Tolva, A., Introzzi, F., & Merli, P. (2009). Il trapianto di cellule staminali emopoietiche nei pazienti affetti da thalassemia major. Hematology Meeting Reports (formerly Haematologica Reports), 1(6). https://doi.org/10.4081/hmr.v1i6.661
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).